What is the difference between desipramine and nortriptyline




















More severe nortriptyline side effects include high fever, difficulty breathing and yellowing of the eyes or skin. Patients experiencing severe reactions to either of these medications should immediately seek professional medical attention.

Regular amitriptyline and nortriptyline use can be habit-forming. Patients may experience withdrawal symptoms such as headache and nausea after abruptly discontinuing use of these medications.

Most doctors will gradually decrease a patient's dose of these medications as part of a post-treatment plan to discourage the development of withdrawal symptoms.

Jay Leone. These medicines can have short-term adverse effects, including confusion and memory loss in older people, but it is less certain whether long-term use increases the risk of dementia. Sarah Berry, a geriatrician and assistant professor of medicine at Harvard Medical School, quoted in a recent article.

For example, selective serotonin reuptake inhibitors SSRIs like citalopram Celexa or fluoxetine Prozac are good alternatives to tricyclic antidepressants. Newer antihistamines such as loratadine Claritin can replace diphenhydramine or chlorpheniramine Chlor-Trimeton. Botox injections and cognitive behavioral training can alleviate urge incontinence.

Use the ACB on-line calculator anticholinergic cognitive burden scale , which ranks these drugs according to the severity of their effects on the mind. This is an essential step forward for scientific knowledge concerning the effects of these drugs. It is unlikely that the fold difference in NRI and SRI affinity between different TCAs is not reflected in differences in their antidepressant effects; yet, 50 years on, high-quality, direct and long-term comparisons are still required to advance knowledge and to serve as a test of the monoamine hypothesis.

An increased focus on collecting quality long-term data on the ability of these drugs to prevent suicide and cause toxicity in over-dose would be valuable. I acknowledge the work and expertise of my wife Isobel, who maintained the computers and programs essential in achieving this review. National Center for Biotechnology Information , U. Journal List Br J Pharmacol v. Br J Pharmacol. Published online Apr Author information Article notes Copyright and License information Disclaimer.

Copyright , Nature Publishing Group. This article has been cited by other articles in PMC. Abstract New data on the pharmacology of tricyclic antidepressants TCAs , their affinities for human cloned CNS receptors and their cytochrome P enzyme inhibition profiles, allow improved deductions concerning their effects and interactions and indicate which of the TCAs are the most useful. Keywords: antidepressive agents, serotonin noradrenaline uptake inhibitors, drug combinations, drug—drug interactions, serotonin toxicity, tyramine pressor test, monoamine oxidase inhibitors.

Introduction There are significant new data concerning the pharmacological properties of tricyclic antidepressants TCAs , and particularly new data resulting from assays using human cloned receptors HCRs , the primary focus in this review, which allow more accurate measurement of affinities at a range of CNS receptors.

General pharmacology The main advances in our understanding of the TCA pharmacology relate to interactions with other drugs, especially interactions involving CYP enzymes, prediction of metabolism from genotyping and to the relative toxicity in overdose of individual drugs. Relative toxicities It is now clearly established, from the prospectively recorded data in the Hunter Area Toxicity Service HATS database of thousands of intoxications with antidepressants, that dothiepin is substantially more toxic in overdose than all the other TCAs; the odds ratio for seizures with dothiepin vs other TCAs was 3.

Table 1 Degree of CYP enzyme inhibition of antidepressant drugs at their usual therapeutic dose. Open in a separate window. Data from Albers et al. Abbreviation: TCA, tricyclic antidepressants. Clomipramine desmethylclomipramine ratio averaged 1 in Japanese vs 0.

CYP2C19 is also important for amitriptyline metabolism Jiang et al. CYP2D6, vs 2C19, inhibitors have a lesser effect on amitriptyline and imipramine levels Leucht et al.

CYP1A2 genotype shows more than fold inter-individual differences in constitutive expression, but no SNP or haplotype has yet been identified that can predict the metabolic phenotype Jiang et al.

Other references Geister et al. Table 2b Cytochrome P enzyme 2D6 metabolism of secondary amine antidepressant drugs. Polymorphisms PM — 5. Data on desipramine Furman et al. Receptor pharmacology Previous estimations of the postsynaptic receptor affinities relied on experiments carried out in various animal tissues and subsequently in human cortical postmortem tissue Richelson, , ; Bolden-Watson and Richelson, Smaller K i values represent greater potency.

Note that no HCR data are known for lofepramine. Table 4 Human cloned receptor data for the affinity of antidepressants at the serotonin and noradrenaline transporters. For human in vivo considerations, the TCAs are grouped as pairs because amitriptyline is metabolized into nortriptyline, clomipramine to desmethylclomipramine, and imipramine to desipramine. Clomipramine is the only available drug with combined K i 's for both transporters greater than 1 n M.

It is unlikely that differing tissue levels would be sufficient to compensate for the low affinity of venlafaxine as an NRI see text.

Table 6 Comparative degree of potency of other TCAs when used at the equivalent sedative H1 antagonist dose of doxepin. This table is like Table 5 , but illustrates the relative potency for producing other effects if the listed drugs are compared as sedatives, at a dose that represents an equivalent H1 antagonist dose vs doxepin given to one decimal rounded to nearest half.

The relationship of receptor affinity and therapeutic effect: serotonin reuptake inhibition and serotonin toxicity If the monoamine theory of depression possesses heuristic utility, then what degree of affinity for the NAT represents a clinically effective level for an antidepressant effect?

The relationship of receptor affinity and therapeutic effect: noradrenaline reuptake inhibition and the pressor response to tyramine Similar considerations may give an indication of what degree of potency constitutes a clinically useful effect on the NAT.

Discussion Research in psychiatry is difficult and, despite many years of effort, it has proved surprisingly hard to produce unequivocal evidence to support the monoamine theory of depression. Abbreviation: NRI, noradrenaline reuptake inhibitors. The table illustrates the relative approximated potency for producing other side effects when the listed drugs are used at a dose that produces equivalent NRI potency to AMI given to one decimal rounded to nearest half.

Conclusions The disadvantages and risks of TCAs have been exaggerated in comparison to newer drugs, perhaps as the result of commercial influences, sponsorship bias and advertising. Acknowledgments I acknowledge the work and expertise of my wife Isobel, who maintained the computers and programs essential in achieving this review. Effect of venlafaxine on imipramine metabolism. Psychiatry Res. Excess fatality from desipramine and dosage recommendations.

Ther Drug Monit. Excess fatality from desipramine in children and adolescents. Clomipramine augmentation in treatment-resistant depression. Depress Anxiety. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta- analysis of efficacy and tolerability. Meta-analytical studies on new antidepressants. Br Med Bull. Curr Treat Opt Neurol. Scope and impact of financial conflicts of interest in biomedical research: a systematic review.

Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs. Br J Clin Pharmacol. Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers. Int J Neuropharmacol. Substrate specific metabolism by polymorphic cytochrome P 2D6 alleles. Toxicol In Vitro. Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci. Moclobemide: therapeutic use and clinical studies.

CNS Drug Rev. Some aspects of genetic polymorphism in the biotransformation of antidepressants. Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data. Can the fatal toxicity Of antidepressant drugs be predicted with pharmacological and toxicological data. Drug Saf. Central and peripheral monoaminergic membrane-pump blockade by some addictive analgesics and antihistamines.

J Pharm Pharmacol. Duloxetine increases serotonin and norepinephrine availability in healthy subjects: a double-blind, controlled study. Low daily mg and mg doses of fluvoxamine inhibit the metabolism of both caffeine cytochrome P A2 and omeprazole cytochrome P C19 Clin Pharmacol Ther.

Effect of mianserin hydrochloride on peripheral uptake mechanisms for noradrenaline and 5-hydroxytryptamine in man. New drugs, old problems: revisiting pharmacological management of treatment-resistant depression.

Adv Psychiatr Treat. Effects of antidepressant drugs on the activity of cytochrome P measured by caffeine oxidation in rat liver microsomes. Pol J Pharmacol. In: Dart RC ed vol. Serotonergic synergism: the risks and benefits of combining the selective serotonin reuptake inhibitors with other serotonergic drugs. Biol Psychiatry. Differential physiological effects of a low dose and high doses of venlafaxine in major depression.

Effects of antidepressant drugs on noradrenaline accumulation and contractile responses in the rat anococcygeus muscle. Reboxetine prevents the tranylcypromine-induced increase in tyramine levels in rat heart.

J Neural Transm. Australian and New Zealand clinical practice guidelines for the treatment of depression. Aust NZ J Psychiatry. Evidence-based pharmacotherapy of obsessive-compulsive disorder.

Impact of CYP2D6 intermediate metabolizer alleles on single-dose desipramine pharmacokinetics. Bioavailability investigation of two different oral formulations of doxepin. Autonomic actions and interactions of mianserin hydrochloride Org. GB 94 and amitriptyline in patients with depressive illness. Psychopharmacology Berl ; 49 — Linezolid and serotonin toxicity.

To the Editor. The relative risk of death from desipramine in suicide attempt is twofold to threefold higher than that of other tricyclic antidepressants. June 1, The increased relative toxicity of desipramine requires explanation.

The pharmacokinetic data of four tricyclic antidepressants listed in the Table show a key difference between tertiary and secondary amines. This distribution pattern implies that desipramine and nortriptyline have. Amitai Y, Frischer H. The Toxicity and Dose of Desipramine Hydrochloride.



0コメント

  • 1000 / 1000